Want to see RLAY full AI Analyst Report?
Relay Therapeutics (RLAY) Ownership Overview
11.59% Insiders
11.21% Mutual Funds
60.03% Other Institutional Investors
14.83% ETFs
2.35% Public Companies and Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 86.07% of the company’s stock is owned by Institutional Investors, 11.59% is owned by Insiders, and 2.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 28, 2026 | xxxxxxxxxxxxx | $116400000 | |
Jul 30, 2026 | xxxxxxxxxxxxx | $27152 | |
Jul 30, 2026 | xxxxxxxxxxxxx | $13920 | |
Jul 30, 2026 | xxxxxxxxxxxxx | $41631 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $263926759 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $52889110 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $17394537 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $7746034 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,904,963 | Insider | 10.00% | 417,070,496 | |
| 14,106,187 | Institution | 6.44% | 268,581,800 | |
| 10,426,652 | Institution | 4.76% | 198,523,454 | |
| 8,270,411 | Institution | 3.77% | 157,468,625 | |
| 7,360,375 | Institution | 3.36% | 140,141,540 | |
| 7,202,265 | Institution | 3.29% | 137,131,126 | |
| 2,826,783 | Institution | 1.29% | 53,821,948 | |
| 1,793,207 | Institution | 0.82% | 34,142,661 | |
| 1,587,378 | Institution | 0.72% | 30,223,677 | |
| 1,532,860 | Institution | 0.70% | 29,185,654 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,202,265 | Institution | 3.29% | 137,131,126 | |
| 1,793,207 | Institution | 0.82% | 34,142,661 | |
| 1,587,378 | Institution | 0.72% | 30,223,677 | |
| 1,528,900 | Institution | 0.70% | 29,110,256 | |
| 1,448,344 | Institution | 0.66% | 27,576,470 | |
| 1,447,360 | Institution | 0.66% | 27,557,734 | |
| 1,299,962 | Institution | 0.59% | 24,751,276 | |
| 943,720 | Institution | 0.43% | 17,968,429 | |
| 813,433 | Institution | 0.37% | 15,487,764 | |
| 683,671 | Institution | 0.31% | 13,017,096 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,825,932 | Institution | 3.11% | 128,532,300 | |
| 6,705,817 | Institution | 3.06% | 127,477,581 | |
| 4,149,921 | Institution | 1.89% | 79,014,496 | |
| 1,951,687 | Institution | 0.89% | 36,750,266 | |
| 1,236,699 | Institution | 0.56% | 23,546,749 | |
| 1,181,845 | Institution | 0.54% | 22,502,329 | |
| 907,089 | Institution | 0.41% | 17,080,486 | |
| 804,017 | Institution | 0.37% | 15,284,363 | |
| 592,247 | Institution | 0.27% | 11,258,615 | |
| 511,870 | Institution | 0.23% | 9,746,005 |
FAQ
Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 60.03% of the company's stock is held by institutional investors, 11.59% is held by insiders, and 2.35% is held by retail investors.
What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 60.03% of Relay Therapeutics (RLAY) stock is held by institutional investors.
What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.35% of Relay Therapeutics (RLAY) stock is held by retail investors.
Who owns the most shares of Relay Therapeutics (RLAY)?
SVF Pauling (Cayman) Ltd owns the most shares of Relay Therapeutics (RLAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.